Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
price fixing
Pharma
Sandoz inks dual settlements to resolve most US antitrust claims
Novartis’ generics and biosimilars spinout Sandoz is plotting its escape from ongoing U.S. litigation tied to alleged generic drug price-fixing.
Fraiser Kansteiner
Aug 3, 2026 10:18am
Sun, Taro ink $200M deal to settle antitrust litigation
Jul 25, 2025 11:08am
Southwest sues generic drugmakers over price-fixing claims
Jul 8, 2025 11:51am
Sandoz shells out $275M in settlement over price-fixing claims
Dec 17, 2024 11:19am
Apotex, Heritage fork over $49M to resolve price-fixing claims
Nov 1, 2024 10:28am
Astellas, AstraZeneca, Glenmark and more—Fierce Pharma Asia
Sep 6, 2024 9:00am
